ZA935648B - Method of enhancing differentiation and survival of neuronal precursor cells - Google Patents

Method of enhancing differentiation and survival of neuronal precursor cells

Info

Publication number
ZA935648B
ZA935648B ZA935648A ZA935648A ZA935648B ZA 935648 B ZA935648 B ZA 935648B ZA 935648 A ZA935648 A ZA 935648A ZA 935648 A ZA935648 A ZA 935648A ZA 935648 B ZA935648 B ZA 935648B
Authority
ZA
South Africa
Prior art keywords
survival
precursor cells
neuronal precursor
enhancing differentiation
differentiation
Prior art date
Application number
ZA935648A
Inventor
Nancy Y Ip
George D Yancopoulos
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of ZA935648B publication Critical patent/ZA935648B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA935648A 1992-08-04 1993-08-04 Method of enhancing differentiation and survival of neuronal precursor cells ZA935648B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92555692A 1992-08-04 1992-08-04

Publications (1)

Publication Number Publication Date
ZA935648B true ZA935648B (en) 1994-08-29

Family

ID=25451901

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA935648A ZA935648B (en) 1992-08-04 1993-08-04 Method of enhancing differentiation and survival of neuronal precursor cells

Country Status (4)

Country Link
AU (1) AU4995193A (en)
IL (1) IL106590A0 (en)
WO (1) WO1994003199A1 (en)
ZA (1) ZA935648B (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981165A (en) * 1991-07-08 1999-11-09 Neurospheres Holdings Ltd. In vitro induction of dopaminergic cells
US7166277B1 (en) 1991-07-08 2007-01-23 Neurospheres Holdings Ltd. Remyelination of neurons using multipotent neural stem cell progeny
US5851832A (en) * 1991-07-08 1998-12-22 Neurospheres, Ltd. In vitro growth and proliferation of multipotent neural stem cells and their progeny
US5750376A (en) * 1991-07-08 1998-05-12 Neurospheres Holdings Ltd. In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny
US6071889A (en) * 1991-07-08 2000-06-06 Neurospheres Holdings Ltd. In vivo genetic modification of growth factor-responsive neural precursor cells
US5980885A (en) * 1991-07-08 1999-11-09 Neurospheres Holdings Ltd. Growth factor-induced proliferation of neural precursor cells in vivo
US6399369B1 (en) 1991-07-08 2002-06-04 Neurospheres Holdings Ltd. Multipotent neural stem cell cDNA libraries
US6294346B1 (en) 1991-07-08 2001-09-25 Neurospheres Holdings, Ltd. Use of multipotent neural stem cells and their progeny for the screening of drugs and other biological agents
US6497872B1 (en) 1991-07-08 2002-12-24 Neurospheres Holdings Ltd. Neural transplantation using proliferated multipotent neural stem cells and their progeny
US7361505B1 (en) 1991-07-08 2008-04-22 Neurospheres Holdings Ltd. Multipotent neural stem cell compositions
FR2717496B1 (en) * 1994-03-18 1996-04-12 Rhone Poulenc Rorer Sa Recombinant viruses, preparation and use in gene therapy.
ZA941729B (en) * 1993-03-12 1994-10-13 Max Planck Gesellschaft Treatment of motor neuron diseases with fibroblast growth factor-5 (fgf-5).
US5817485A (en) * 1994-03-08 1998-10-06 Human Genome Sciences, Inc. Nucleic acids and cells for recombinant production of fibroblast growth factor-10
US5935849A (en) * 1994-07-20 1999-08-10 Cytotherapeutics, Inc. Methods and compositions of growth control for cells encapsulated within bioartificial organs
US5795790A (en) * 1994-07-20 1998-08-18 Cytotherapeutics, Inc. Method for controlling proliferation and differentiation of cells encapsulated within bioartificial organs
GB9422643D0 (en) * 1994-11-08 1995-01-04 Stringer Bradley M J Neural cell lines
AU716811B2 (en) * 1994-11-14 2000-03-09 Neurospheres Holdings Ltd Regulation of neural stem cell proliferation
GB9505663D0 (en) * 1995-03-21 1995-05-10 Stringer Bradley M J Genetically modified neural cells
AU750828B2 (en) * 1995-03-21 2002-08-01 Cellfactors Plc Cell culture method
WO1996033731A1 (en) * 1995-04-26 1996-10-31 Regeneron Pharmaceuticals, Inc. Methods of using neurotrophic factors to enhance neuronal grafts
US6495364B2 (en) 1995-05-23 2002-12-17 Neurotech, S.A. Mx-1 conditionally immortalized cells
US7544511B2 (en) 1996-09-25 2009-06-09 Neuralstem Biopharmaceuticals Ltd. Stable neural stem cell line methods
AU749530B2 (en) * 1997-06-11 2002-06-27 Acorda Therapeutics, Inc. CNS neuroregenerative compositions and methods of use
US6277820B1 (en) 1998-04-09 2001-08-21 Genentech, Inc. Method of dopaminergic and serotonergic neuron formation from neuroprogenitor cells
DE19837230A1 (en) * 1998-08-17 2000-03-09 Jean Krutmann Use of neurotrophin-4 as a therapeutic agent, especially for treating melanoma
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
WO2001000662A2 (en) * 1999-06-29 2001-01-04 Eli Lilly And Company The use of human fgh-8 polypeptides as neurotrophic agents
US6749850B1 (en) 1999-08-18 2004-06-15 The General Hospital Corporation Methods, compositions and kits for promoting recovery from damage to the central nervous system
AU6790300A (en) * 1999-08-18 2001-03-13 Children's Medical Center Corporation Methods, compositions and kits for promoting recovery from damage to the central nervous system
US20050042749A1 (en) 2001-05-16 2005-02-24 Carpenter Melissa K. Dopaminergic neurons and proliferation-competent precursor cells for treating Parkinson's disease
US7250294B2 (en) 2000-05-17 2007-07-31 Geron Corporation Screening small molecule drugs using neural cells differentiated from human embryonic stem cells
GB2379447B (en) 2000-05-17 2004-12-29 Geron Corp Neural progenitor cell populations
AU2003213078A1 (en) 2002-02-14 2003-09-04 Buck Institute Neurogenerative or neurotrophic factors for mitigating a symptom of ischemia
US20040185429A1 (en) 2002-12-09 2004-09-23 Judith Kelleher-Andersson Method for discovering neurogenic agents
US8293488B2 (en) 2002-12-09 2012-10-23 Neuralstem, Inc. Method for screening neurogenic agents
EP3000877B1 (en) 2004-06-09 2019-08-14 The University Court of the University of Edinburgh Neural stem cells
EP2913393B8 (en) 2004-11-17 2020-02-26 Seneca Biopharma, Inc. Transplantation of human neural cells for treatment of neurodegenerative conditions
EP3187581A1 (en) 2008-12-23 2017-07-05 BOCO Silicon Valley, Inc. Target populations of oligodendrocyte precursor cells and methods of making and using same
CA2806904C (en) 2010-07-28 2018-11-27 Neuralstem, Inc. Methods for treating and/or reversing neurodegenerative diseases and/or disorders
KR102100021B1 (en) 2014-10-20 2020-04-13 뉴럴스템, 인크. Stable neural stem cells comprising an exogenous polynucleotide coding for a growth factor and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005138A1 (en) * 1988-11-08 1990-05-17 The Children's Medical Center Corporation Cytotoxic amyloid precursors and screening assays using them
US5229500A (en) * 1989-08-30 1993-07-20 Regeneron Pharmaceuticals, Inc. Brain derived neurotrophic factor
IE903130A1 (en) * 1989-09-15 1991-03-27 Regeneron Pharma Ciliary neurotrophic factor

Also Published As

Publication number Publication date
AU4995193A (en) 1994-03-03
WO1994003199A1 (en) 1994-02-17
IL106590A0 (en) 1993-12-08

Similar Documents

Publication Publication Date Title
ZA935648B (en) Method of enhancing differentiation and survival of neuronal precursor cells
GB9411488D0 (en) Method of magnetically stimulating neural cells
GB2278236B (en) Photovoltaic cell and method
IL106787A0 (en) Electrochemical cell and its production
HUT64764A (en) Carbapenem-derivatives with antibiotic effect and medical preparatives containing them and process for the production thereof
EP0515186A3 (en) Densified porous billets and process
EP0581964A4 (en) Method of producing thin cell
GB9208921D0 (en) Electrochemical treatment of surfaces
EP0735894A4 (en) Composition and methods to improve neural outcome
GB9319987D0 (en) Dram and controller
EP0562308A3 (en) Charge plate connectors and method of making
AU4233593A (en) Moving harness and method of use
GB2267529B (en) Doors and methods of forming doors
ZA9210101B (en) Solid matal-carbon matrix of metallofullerites and method of forming same
GB9215710D0 (en) Analysis of cells
PL301204A1 (en) Method of obtaining avermectines and invermectines
GB2289708B (en) Doors and Methods of Forming Doors
IL107212A0 (en) Method and device for the cultivation of cells
GB2273671B (en) Method of simultaneously milling and drying
EP0564212A3 (en) Process for the preparation of arylethylamines and substituted arylethylamines
EP0564213A3 (en) Process for the preparation of arylethylamines and substituted arylethylamines
HUT64757A (en) Process for the production of n-tetrahydrofuryl-piperidine-derivatives and of medical preparatives containing them
EP0559175A3 (en) Gamma-polyglutamate hydrolase and process for producing same
GB2279331B (en) Container and method of making the container
ZA923937B (en) Structural member and method of manufacture